China · Delayed Price · Currency is CNY Shanghai Fosun Pharmaceutical (Group) Company Description
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. manufactures, distributes, and sells pharmaceutical products in Mainland China and internationally.
The company offers pharmaceutical products for anti-tumor and immune modulation, metabolism and alimentary system, anti-infection, central nervous system, and cardiovascular system; and APIs and intermediates, including amino acid, tranexamic acid, levamisole hydrochloride, and clindamycin hydrochloride.
It also provides mRNA vaccines for Covid-19; medical devices for medical cosmetology respiratory health and professional medical products; oncology, neuroscience and other specialty fields; and solutions for infections, tumors, the central nervous system, and chronic diseases.
In addition, the company offers online and offline medical services, such as pharmaceuticals and medical devices, consumer healthcare and special commodities; specialized medical disciplines; and insurance services.
Further, it is involved in the import and export of medical equipment and the provision of related and other consulting services and investment management.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
| Country | China |
| Founded | 1994 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 40,557 |
| CEO | Yi Liu |
Contact Details
Address: Building A Shanghai, 200233 China | |
| Phone | 86 21 3398 7000 |
| Website | fosunpharma.com |
Stock Details
| Ticker Symbol | 600196 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000X38 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Wenjie Zhang | Co-President and Co-Chief Executive Officer of Innovative Medicines Division |
| Wang Xingli M.D., Ph.D. | Co-President, Co-Chairman and Co-Chief Executive Officer of Innovative Drug Div., CEO of Global Research & Development Center |
| Jing Li | Co-President and Chief Executive Officer of Established Medicines Manufacturing and Supply Division |
| Dr. Yi Liu | President, Chief Executive Officer and Chairman, CEO of Fosun MedTech Div.& CEO of the Diagnostic Tech. Div. |
| Xiaohui Guan | Executive Co-Chairman |
| Yuqing Chen | Executive Chairman |
| Rongli Feng | Executive President and Chief Human Resources Officer |
| Zhanyu Chen | Senior Vice President and Chief Financial Officer |
| Yue Zhu | Vice President and GM of Legal Department |
| Kexin Wang | Executive Director |